Ask AI
ProCE Banner Activity

Advances in HBV/HDV Management: Top Data From EASL 2025

Clinical Thought

Gain an understanding of the novel treatments for managing hepatitis B virus (HBV) and hepatitis D virus (HDV) infection that were presented at EASL Congress 2025 and how these advancements are bringing us closer to curing HBV. 

Released: June 06, 2025

Expiration: June 05, 2026

Review Activity

Share

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.

Disclosure

Primary Author

Maria Buti, MD: consultant/advisor/speaker: AbbVie, Gilead Sciences, GlaxoSmithKline, Janssen, Vir.